This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]
| p/e | p/bv | ROE | dy | market cap |
net margin |
|
|---|---|---|---|---|---|---|
| 26.05 | 6.75 | 25.92% | 2.29% | $ 548.05 B | 21.83% | |
| 19.76 | 1.65 | 8.35% | 6.37% | $ 153.52 B | 12.42% | |
| 83.09 | 0.00 | 0.00% | 3.35% | $ 351.12 B | 6.91% | |
| 11.67 | 6.01 | 51.50% | 4.53% | $ 182.84 B | 33.05% | |
| 15.22 | 0.00 | 0.00% | 2.97% | $ 277.74 B | 28.08% | |
| 28.78 | 6.04 | 20.99% | 1.69% | $ 294.30 B | 17.41% | |
| 19.03 | 7.16 | 37.62% | 2.45% | $ 161.96 B | 28.90% | |
| 16.77 | -3.48 | -20.72% | 4.28% | $ 118.31 B | 14.64% | |
| 19.15 | 15.37 | 80.25% | 1.74% | $ 51.19 B | 28.23% | |
| 17.18 | 2.48 | 14.41% | 0.48% | $ 77.41 B | 31.41% | |
| 24.34 | 158.01 | 649.21% | 0.00% | $ 7.71 B | 22.69% | |
| 24.08 | 21.45 | 89.06% | 2.80% | $ 185.71 B | 20.98% | |
| 23.47 | -1,028.86 | -4,383.84% | 0.38% | $ 101.86 B | 1.09% | |
| 27.65 | 5.86 | 21.18% | 0.00% | $ 109.29 B | 32.94% | |
| 11.06 | 2.02 | 18.24% | 0.00% | $ 1.76 B | 18.27% | |
| 28.38 | -17.47 | -61.56% | 1.02% | $ 47.16 B | 0.68% | |
| 18.24 | 5.61 | 30.78% | 0.00% | $ 2.68 B | 28.80% | |
| 20.96 | 1.48 | 7.08% | 0.00% | $ 27.10 B | 13.07% |
R$ 1.000,00 in PETR4 You would now have R$ 2.294,60
R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60
type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 08/30/2016 | 12/15/2016 | 0,38150000 |
Average Investor10 user rating
4.0
(1 people)
Founded: 2006
Time since IPO - - year
Employees
BIND Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-3.35 Millions.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, BIND Therapeutics Inc. reported $14.85 Millions in revenue, generating net income of $-21.69 Millions.
Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.
The company trades under the ticker BIND.
Market cap
$ -
$ -
Net worth
$ -3.35 Millions
$ -3,352,000.00
Assets
$ 23.44 Millions
$ 23,440,000.00
Total Shares Outstanding
20.88 Millions
20,884,000
Average Daily Trading Volume
$ 351.00
$ 351.00
Sector
Health Care
Industry
Biotechnology
Shares
0.00
0.00%
-893.55%
0.00
23.47
0.38%
-4,383.84%
-1,028.86
28.38
1.02%
-61.56%
-17.47
26.05
2.29%
25.92%
6.75
19.76
6.37%
8.35%
1.65
83.09
3.35%
0.00%
0.00
15.22
2.97%
0.00%
0.00
28.78
1.69%
20.99%
6.04
0.00
0.00%
-893.55%
0.00
23.47
0.38%
-4,383.84%
-1,028.86
28.38
1.02%
-61.56%
-17.47
26.05
2.29%
25.92%
6.75
19.76
6.37%
8.35%
1.65
83.09
3.35%
0.00%
0.00
15.22
2.97%
0.00%
0.00
28.78
1.69%
20.99%
6.04
The current price of BIND Therapeutics (BIND) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.
BIND Therapeutics (BIND) did not pay dividends over the past year.
BIND Therapeutics (BIND) is currently trading at $ 0.00 with a P/E ratio of 0.00%. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of -%. The total shareholder return over the same period was 0.00%.
Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.
You can buy BIND Therapeutics (BIND) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol BIND and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.
Over the past month, BIND Therapeutics (BIND) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.
In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of -%.
If you were to purchase 100 shares of BIND Therapeutics (BIND) today at the current price of $ 0.00 your total investment would be $ 0.00.
Based on historical performance, the investment would have grown to approximately:
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Register
Already have an account? Login
Register
Register for free to continue accessing Investor10.
Already have an account? Login
Tesla
Dividend Calendar
Stock Rankings
ETF Rankings
Crypto Rankings
